Study Involvement Is Not Conflict For Advisory Cmte Members – FDA’s Temple
This article was originally published in The Tan Sheet
Executive Summary
Conducting clinical trials for a manufacturer generally does not pose a conflict of interest risk for advisory committee members, FDA Office of Medical Policy Director Robert Temple said Aug. 23